Biotechnology stocks
1,362 listed biotechnology companies, ordered by market capitalisation, inside the Health Care sector. Every one has a free page with its price history, key figures and Tweenvest factor scores.
| Company | Market cap | Price | Day |
|---|---|---|---|
| ProKidney Corp.NasdaqCM: PROK | $277.87M | $1.33 | -23.56% |
| Cypherpunk Technologies Inc.NasdaqCM: CYPH | $276.95M | $2.57 | -12.59% |
| ROKIT Healthcare Inc.KOSDAQ: A376900 | $276.77M | ₩21,250.00 | -20.86% |
| Surrozen, Inc.NasdaqCM: SRZN | $275.50M | $23.44 | -21.05% |
| Orum Therapeutics, Inc.KOSDAQ: A475830 | $274.11M | ₩16,800.00 | -12.82% |
| Anika Therapeutics, Inc.NasdaqGS: ANIK | $273.55M | $20.44 | +1.09% |
| Curocell Inc.KOSDAQ: A372320 | $268.40M | ₩23,500.00 | -10.13% |
| Intelligene Inc.TPEX: 7832 | $268.15M | NT$15.00 | +7.14% |
| Santhera Pharmaceuticals Holding AGSWX: SANN | $267.82M | CHF14.42 | +0.98% |
| Northwest Biotherapeutics, Inc.OTCPK: NWBO | $266.93M | $0.16 | -0.32% |
| AprilBio Co.,Ltd.KOSDAQ: A397030 | $264.94M | ₩12,840.00 | -11.81% |
| Mabpharm LimitedSEHK: 2181 | $262.75M | HK$0.50 | -0.99% |
| Jiangsu Gdk Biological Technology Co., LtdSHSE: 688670 | $259.80M | CN¥14.11 | -26.40% |
| Q32 Bio Inc.NasdaqCM: QTTB | $257.51M | $8.65 | -1.70% |
| VISEN PharmaceuticalsSEHK: 2561 | $256.95M | HK$18.45 | -0.86% |
| X4 Pharmaceuticals, Inc.NasdaqCM: XFOR | $256.79M | $2.59 | -11.00% |
| Clover Biopharmaceuticals, Ltd.SEHK: 2197 | $254.79M | HK$1.54 | -13.73% |
| PharmaEngine, Inc.TPEX: 4162 | $254.19M | NT$57.40 | +0.35% |
| Abeona Therapeutics Inc.NasdaqCM: ABEO | $253.33M | $4.43 | -10.32% |
| Clinuvel Pharmaceuticals LimitedASX: CUV | $252.53M | AU$7.12 | +0.71% |
| Ocugen, Inc.NasdaqCM: OCGN | $250.84M | $0.74 | -6.37% |
| Vicore Pharma Holding AB (publ)OM: VICO | $250.44M | Skr8.81 | -2.11% |
| Tanvex BioPharma, Inc.TWSE: 6541 | $249.92M | NT$30.60 | -9.87% |
| Cabaletta Bio, Inc.NasdaqGS: CABA | $249.23M | $1.47 | -3.29% |
| Obigen Pharma Inc.TPEX: 7876 | $248.53M | NT$75.20 | -3.84% |
| Bicycle Therapeutics plcNasdaqGS: BCYC | $248.47M | $3.55 | -2.47% |
| Century Therapeutics, Inc.NasdaqCM: IPSC | $248.07M | $1.37 | -6.80% |
| Lineage Cell Therapeutics, Inc.NYSEAM: LCTX | $247.42M | $0.98 | -1.58% |
| Inventage Lab, Inc.KOSDAQ: A389470 | $247.05M | ₩24,750.00 | -6.95% |
| AIM Vaccine Co., Ltd.SEHK: 6660 | $246.16M | HK$1.58 | -12.26% |
| Palisade Bio, Inc.NasdaqCM: PALI | $245.72M | $1.41 | -8.44% |
| Vanda Pharmaceuticals Inc.NasdaqGM: VNDA | $243.66M | $4.03 | -11.82% |
| Healios K.K.TSE: 4593 | $241.24M | ¥281.00 | -6.95% |
| Shandong Boan Biotechnology Co., Ltd.SEHK: 6955 | $240.28M | HK$3.03 | -2.26% |
| Rocket Pharmaceuticals, Inc.NasdaqGM: RCKT | $239.31M | $2.18 | -14.84% |
| Amarin Corporation plcNasdaqCM: AMRN | $239.11M | $11.32 | -5.90% |
| Adimmune CorporationTWSE: 4142 | $239.04M | NT$18.40 | -4.17% |
| AC Immune SANasdaqGM: ACIU | $237.63M | $2.39 | -4.40% |
| Acepodia, Inc.TPEX: 6976 | $237.24M | NT$13.20 | -1.49% |
| HansBiomed CorporationKOSDAQ: A042520 | $233.19M | ₩21,800.00 | +5.57% |
| Immuneering CorporationNasdaqGM: IMRX | $232.26M | $3.59 | -8.88% |
| Panacea Biotec LimitedNSEI: PANACEABIO | $232.14M | Rs359.70 | +4.19% |
| OBI Pharma, Inc.TPEX: 4174 | $230.76M | NT$56.90 | +5.96% |
| Polaris GroupTWSE: 6550 | $230.67M | NT$16.10 | -3.59% |
| SAB Biotherapeutics, Inc.NasdaqCM: SABS | $230.20M | $2.53 | -15.10% |
| InflaRx N.V.NasdaqGS: IFRX | $229.89M | $1.56 | +1.96% |
| Oryzon Genomics S.A.BME: ORY | $229.46M | €2.50 | -1.19% |
| BridgeBio Oncology Therapeutics, Inc.NasdaqGM: BBOT | $226.09M | $2.82 | -14.80% |
| SillaJen, Inc.KOSDAQ: A215600 | $225.52M | ₩2,170.00 | -7.26% |
| HighTide Therapeutics, Inc.SEHK: 2511 | $225.32M | HK$3.10 | -9.64% |
| Tetratherix LimitedASX: TTX | $223.72M | AU$6.06 | -4.42% |
| TriSalus Life Sciences, Inc.NasdaqGM: TLSI | $223.52M | $3.63 | -10.59% |
| EuBiologics Co., Ltd.KOSDAQ: A206650 | $222.74M | ₩8,080.00 | -4.04% |
| Spectral Medical Inc.TSX: EDT | $222.34M | CA$1.07 | -3.60% |
| ToolGen IncorporatedKOSDAQ: A199800 | $218.79M | ₩29,850.00 | -10.76% |
| Valerio Therapeutics Société anonymeENXTPA: ALVIO | $218.40M | €0.39 | -1.01% |
| Lexeo Therapeutics, Inc.NasdaqGM: LXEO | $216.59M | $2.64 | -18.27% |
| Fate Therapeutics, Inc.NasdaqGM: FATE | $214.48M | $1.79 | -17.89% |
| Greenwich LifeSciences, Inc.NasdaqCM: GLSI | $213.57M | $14.55 | -11.98% |
| Guangzhou Innogen Pharmaceutical Group Co., LtdSEHK: 2591 | $212.17M | HK$3.65 | +1.25% |
| Racura Oncology LtdASX: RAC | $212.14M | AU$1.56 | -14.33% |
| Keros Therapeutics, Inc.NasdaqGM: KROS | $211.36M | $10.66 | -10.79% |
| ImmuneOncia Therapeutics, Inc.KOSDAQ: A424870 | $209.10M | ₩3,050.00 | -7.58% |
| Transgene SAENXTPA: TNG | $208.56M | €0.68 | +0.29% |
| Larimar Therapeutics, Inc.NasdaqGM: LRMR | $207.20M | $1.99 | -25.66% |
| Protalix BioTherapeutics, Inc.NYSEAM: PLX | $205.46M | $2.55 | -0.78% |
| Zentalis Pharmaceuticals, Inc.NasdaqGM: ZNTL | $201.65M | $2.13 | -19.32% |
| Hester Biosciences LimitedBSE: 524669 | $200.77M | Rs2,239.95 | +9.70% |
| Pyxis Oncology, Inc.NasdaqGS: PYXS | $200.69M | $1.68 | -17.24% |
| PegBio Co., Ltd.SEHK: 2565 | $200.33M | HK$4.02 | -14.29% |
| Japan Tissue Engineering Co., Ltd.TSE: 7774 | $199.60M | ¥776.00 | -2.14% |
| Lyell Immunopharma, Inc.NasdaqGS: LYEL | $198.98M | $8.12 | -6.77% |
| Camp4 Therapeutics CorporationNasdaqGM: CAMP | $198.93M | $3.17 | -15.92% |
| Thor Medical ASAOB: TRMED | $198.67M | Nkr4.44 | -0.34% |
| TaiGen Biopharmaceuticals Holdings LimitedTPEX: 4157 | $196.58M | NT$8.96 | -3.97% |
| S.Biomedics Co., Ltd.KOSDAQ: A304360 | $195.55M | ₩21,050.00 | -3.22% |
| SinoMab BioScience LimitedSEHK: 3681 | $194.36M | HK$1.10 | -4.35% |
| Cartesian Therapeutics, Inc.NasdaqGM: RNAC | $189.70M | $6.27 | -11.13% |
| Beijing Biostar Pharmaceuticals Co., Ltd.SEHK: 2563 | $188.64M | HK$3.80 | -11.63% |
| Akebia Therapeutics, Inc.NasdaqCM: AKBA | $185.66M | $0.67 | -16.36% |
| Compugen Ltd.NasdaqCM: CGEN | $185.66M | $1.96 | -7.98% |
| Evommune, Inc.NYSE: EVMN | $185.09M | $5.10 | -2.11% |
| ProQR Therapeutics N.V.NasdaqCM: PRQR | $184.87M | $1.31 | -19.63% |
| Shanghai Rightongene Biotechnology Co., Ltd.SHSE: 688217 | $184.83M | CN¥22.41 | -9.75% |
| Genome & CompanyKOSDAQ: A314130 | $184.57M | ₩4,705.00 | -13.99% |
| Perspective Therapeutics, Inc.NYSEAM: CATX | $183.78M | $1.61 | -28.76% |
| Precision BioSciences, Inc.NasdaqCM: DTIL | $183.27M | $6.64 | -2.06% |
| Invivyd, Inc.NasdaqGM: IVVD | $182.34M | $0.62 | -14.23% |
| Sutro Biopharma, Inc.NasdaqGM: STRO | $181.40M | $10.94 | -23.34% |
| ADC Therapeutics SANYSE: ADCT | $178.73M | $1.40 | -19.08% |
| Alpha Cognition Inc.NasdaqCM: ACOG | $178.36M | $8.19 | -9.40% |
| HLB Therapeutics Co.,Ltd.KOSDAQ: A115450 | $176.84M | ₩2,675.00 | -15.75% |
| Uwell Biopharma, Inc.TPEX: 7902 | $176.83M | NT$28.60 | +2.14% |
| Korro Bio, Inc.NasdaqCM: KRRO | $176.41M | $11.98 | -0.58% |
| Exagen Inc.NasdaqGM: XGN | $176.12M | $7.27 | -2.81% |
| Sionna Therapeutics, Inc.NasdaqGM: SION | $175.88M | $3.89 | -20.61% |
| Genomictree Inc.KOSDAQ: A228760 | $175.27M | ₩9,520.00 | -15.90% |
| PepGen Inc.NasdaqGS: PEPG | $174.53M | $2.52 | -6.67% |
| Eledon Pharmaceuticals, Inc.NasdaqCM: ELDN | $173.26M | $2.13 | -14.11% |
| ALX Oncology Holdings Inc.NasdaqGS: ALXO | $171.46M | $1.24 | +8.77% |